Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 7;14(6):854-861.
doi: 10.2215/CJN.14831218. Epub 2019 May 23.

Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience

Affiliations

Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience

Mark E Molitch et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Glomerular hyperfiltration has been considered to be a contributing factor to the development of diabetic kidney disease (DKD). To address this issue, we analyzed GFR follow-up data on participants with type 1 diabetes undergoing 125I-iothalamate clearance on entry into the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications study.

Design, setting, participants, & measurements: This was a cohort study of DCCT participants with type 1 diabetes who underwent an 125I-iothalamate clearance (iGFR) at DCCT baseline. Presence of hyperfiltration was defined as iGFR levels ≥140 ml/min per 1.73 m2, with secondary thresholds of 130 or 150 ml/min per 1.73 m2. Cox proportional hazards models assessed the association between the baseline hyperfiltration status and the subsequent risk of reaching an eGFR <60 ml/min per 1.73 m2.

Results: Of the 446 participants, 106 (24%) had hyperfiltration (iGFR levels ≥140 ml/min per 1.73 m2) at baseline. Over a median follow-up of 28 (interquartile range, 23, 33) years, 53 developed an eGFR <60 ml/min per 1.73 m2. The cumulative incidence of eGFR <60 ml/min per 1.73 m2 at 28 years of follow-up was 11.0% among participants with hyperfiltration at baseline, compared with 12.8% among participants with baseline GFR <140 ml/min per 1.73 m2. Hyperfiltration was not significantly associated with subsequent risk of developing an eGFR <60 ml/min per 1.73 m2 in an unadjusted Cox proportional hazards model (hazard ratio, 0.83; 95% confidence interval, 0.43 to 1.62) nor in an adjusted model (hazard ratio, 0.77; 95% confidence interval, 0.38 to 1.54). Application of alternate thresholds to define hyperfiltration (130 or 150 ml/min per 1.73 m2) showed similar findings.

Conclusions: Early hyperfiltration in patients with type 1 diabetes was not associated with a higher long-term risk of decreased GFR. Although glomerular hypertension may be a mechanism of kidney injury in DKD, higher total GFR does not appear to be a risk factor for advanced DKD.

Keywords: DCCT/EDIC; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Incidence; Iothalamic Acid; Kidney Glomerulus; Proportional Hazards Models; diabetes mellitus; glomerular filtration rate; glomerular hyperfiltration; hypertension; iothalamate GFR; kidney; risk factors.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Kaplan–Meier survival curves and 95% CIs for developing an eGFR <60 ml/min per 1.73 m2 show no difference for those with hyperfiltration (eGFR >140 ml/min per 1.73 m2) compared to those without hyperfiltration (eGFR <140 ml/min per 1.73 m2).
Figure 2.
Figure 2.
Risk gradient showing the log hazard rate (and 95% pointwise CIs) for the development of an eGFR <60 ml/min per 1.73 m2 as a function of the iothalamate GFR.

Comment in

  • Hyperfiltration: Much Ado about Nothing?
    Tummalapalli SL, Shlipak MG. Tummalapalli SL, et al. Clin J Am Soc Nephrol. 2019 Jun 7;14(6):789-791. doi: 10.2215/CJN.05330419. Epub 2019 May 23. Clin J Am Soc Nephrol. 2019. PMID: 31175079 Free PMC article. No abstract available.

References

    1. Mogensen CE: Glomerular hyperfiltration in human diabetes. Diabetes Care 17: 770–775, 1994 - PubMed
    1. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49: 1774–1777, 1996 - PubMed
    1. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ: The clinical significance of hyperfiltration in diabetes. Diabetologia 53: 2093–2104, 2010 - PubMed
    1. Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH, Joles JA: Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment. J Am Soc Nephrol 28: 1023–1039, 2017 - PMC - PubMed
    1. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82: 5963–5967, 1985 - PMC - PubMed

Publication types